Gap Between “Hobbits” and Modern Humans Narrows

Remnants of fires indicate modern humans may have lived around the same time as Homo floresiensis.

Written byTanya Lewis
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

Homo floresiensis skullUNIVERSITY OF WOLLONGONGNew research suggests that Homo floresiensis—ancient hominins often called “hobbits”—lived closer in time to modern humans than previously thought. Researchers from the University of Wollongong in Australia have found evidence that modern humans were using fire on the Indonesian island of Flores as far back as 41,000 years ago, whereas the hobbits lived until roughly 50,000 years ago, the team reported today (June 30) in the Journal of Archaeological Science.

“This new evidence, which is some of the earliest evidence of modern human activity in Southeast Asia, narrows the gap between the two hominin species at the site,” geoarchaeologist Mike Morley of Wollongong said in a statement. Because there has been no evidence that hobbits used fire, Morley noted that the fires were most likely built by modern humans.

The researchers were part of the team that first discovered H. floresiensis at a cave in Flores, called Liang Bua, in 2003. A March study dated some hobbit bones to between 100,000 and 60,000 years old, and stone tools found at the site to 190,000 to 50,000 years old. But there was a gap in the record from 46,000 to 20,000 years ago, according to the ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Related Topics

Meet the Author

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies